Risk factors for colorectal cancer in a fecal immunochemical test‐positive group: The National Health Insurance Service‐National Health Screening Cohort
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Joo Hyun Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea. Hauptthemen laut MEDLINE: Early Detection of Cancer, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center, National Health Insurance Service Ilsan Hospital, NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL.
Abstract (Originalsprache)
Background and Aim Colorectal cancer (CRC) was the fourth most common cancer in Republic of Korea in 2019. It has a gradually increasing mortality rate, indicating the importance of screening for CRC. Among the various CRC screening test, fecal immunochemical test (FIT) is a simple yet most commonly used. Neverthelss, there have been only few long‐term studies on subjects with FIT‐positive. Therefore, in this study, we aimed to investigate the risk factors for CRC in FIT‐positive patients using the National Health Insurance Service Bigdata database.
Methods
Among 1 737 633 individuals with a FIT screening result for CRC in 2009, 101 143 (5.82%) were confirmed to be FIT positive. The CRC incidence over 10 years (up to 2018) of these participants was investigated using the National Cancer Registry.
Results
Out of the 101 143 FIT‐positive participants, 4395 (4.35%) were diagnosed with CRC. The FIT‐positive patients who underwent a second round of screening showed a 5‐year cumulative CRC incidence of approximately 1.25%, whereas those who did not showed an incidence of approximately 3.75%. Among the FIT‐positive patients, the CRC incidence in the non‐compliance group for the second round of screening was 2.8 times higher than that in the compliance group.
Conclusions
In FIT‐positive participants, non‐compliance with the second round of screening was identified as a major risk factor for CRC development. It is necessary to establish appropriate strategies for managing risk factors for CRC in FIT‐positive patients to increase the rate of compliance with the second round of CRC screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
- Research Institute, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
- Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
- Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
ORCID-Profile: Joo Hyun Park, Kyung Hee Cho, Junho Choi, Sungyoun Chun, Jae Kwang Lee, Hyunsoon Cho, Bun Kim
Förderung
- National Cancer Center
- National Health Insurance Service Ilsan Hospital
- NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL
Zitieren
APA
Park, J. H., Cho, K. H., Choi, J., Chun, S., Lee, J. K., Cho, H., & Kim, B. (2024). Risk factors for colorectal cancer in a fecal immunochemical test‐positive group: The National Health Insurance Service‐National Health Screening Cohort. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16374
Vancouver
Park JH, Cho KH, Choi J, Chun S, Lee JK, Cho H, et al. Risk factors for colorectal cancer in a fecal immunochemical test‐positive group: The National Health Insurance Service‐National Health Screening Cohort. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16374
BibTeX
@article{Park2024,
author = {Park, Joo Hyun and Cho, Kyung Hee and Choi, Junho and Chun, Sungyoun and Lee, Jae Kwang and Cho, Hyunsoon and Kim, Bun},
title = {Risk factors for colorectal cancer in a fecal immunochemical test‐positive group: The National Health Insurance Service‐National Health Screening Cohort},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16374}
}
EUVIMED